{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 21652.591727000014, "input_tokens": 216, "output_tokens": 193, "tokens_per_second": 8.913482618311038, "gold_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "HDAC8", "therapy_name": "Abexinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed"], "ref_ids": ["16731764", "20145726", "25520806"], "ref_urls": ["http://europepmc.org/abstract/MED/16731764", "http://europepmc.org/abstract/MED/20145726", "http://europepmc.org/abstract/MED/25520806"]}, {"gene_symbol": "HDAC8", "therapy_name": "Belinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/206256lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206256lbl.pdf"]}, {"gene_symbol": "HDAC8", "therapy_name": "Panobinostat", "targets_moa": "Histone deacetylase inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2015/205353s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf"]}], "id": "F3.2-000162-P1", "question": "Which drugs target both HDAC8 and HDAC9?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('HDAC8')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('HDAC8'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('HDAC9')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('HDAC9'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 14811.160747999964, "input_tokens": 215, "output_tokens": 189, "tokens_per_second": 12.760647407430357, "gold_rows": [{"gene_symbol": "ALK", "therapy_name": "Alectinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Ceritinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Crizotinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Lorlatinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "ALK", "therapy_name": "Alectinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2015/208434s000lbl.pdf", "nda/2015/208434Orig1s000ClinPharmR.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208434Orig1s000ClinPharmR.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Ceritinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2014/205755s000lbl.pdf", "label/2017/205755s009lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Crizotinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK | NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)", "ref_sources": ["FDA", "FDA"], "ref_ids": ["label/2012/202570s003lbl.pdf", "label/2017/202570s021lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202570s003lbl.pdf", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202570s021lbl.pdf"]}, {"gene_symbol": "ALK", "therapy_name": "Lorlatinib", "targets_moa": "ALK tyrosine kinase receptor inhibitor | EML4-ALK  inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2018/210868s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf"]}], "id": "F3.2-000005-P1", "question": "Which drugs target both ALK and EML4?", "gold_cypher": "MATCH (t:Therapy)-[r1:TARGETS]->(g1:Gene)\nWHERE toLower(g1.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g1.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (t)-[r2:TARGETS]->(g2:Gene)\nWHERE toLower(g2.symbol) = toLower('EML4')\n   OR any(s IN coalesce(g2.synonyms, []) WHERE toLower(s) = toLower('EML4'))\nRETURN\n  g1.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r1.moa AS targets_moa,\n  coalesce(r1.ref_sources, []) AS ref_sources,\n  coalesce(r1.ref_ids, []) AS ref_ids,\n  coalesce(r1.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('FGFR2')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\n  OR toLower(g.symbol) = toLower('FGFR3')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 13360.913474000028, "input_tokens": 216, "output_tokens": 169, "tokens_per_second": 12.648835749806281, "gold_rows": [{"gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Lucitanib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://bit.ly/1ZGqyT3", "21212416", "22304225"], "ref_urls": ["http://bit.ly/1ZGqyT3", "http://europepmc.org/abstract/MED/21212416", "http://europepmc.org/abstract/MED/22304225"]}, {"gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR2", "therapy_name": "TRK Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}, {"gene_symbol": "FGFR3", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Dovitinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pazopanib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR3", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "generated_rows": [{"gene_symbol": "FGFR2", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR2", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR2", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Lucitanib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://bit.ly/1ZGqyT3", "21212416", "22304225"], "ref_urls": ["http://bit.ly/1ZGqyT3", "http://europepmc.org/abstract/MED/21212416", "http://europepmc.org/abstract/MED/22304225"]}, {"gene_symbol": "FGFR2", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR2", "therapy_name": "TRK Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "FGFR2", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 2 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}, {"gene_symbol": "FGFR3", "therapy_name": "AZD-4547", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/", "22369928"], "ref_urls": ["http://europepmc.org/abstract/MED/22369928", "http://openinnovation.astrazeneca.com/what-we-offer/compound/azd4547/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Derazantinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"], "ref_urls": ["http://meetinglibrary.asco.org/content/149025-156", "http://www.arqule.com/res/pip/"]}, {"gene_symbol": "FGFR3", "therapy_name": "Dovitinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "FGFR3", "therapy_name": "Erdafitinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/212018s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Futibatinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["https://cancerres.aacrjournals.org/content/80/22/4986", "33054456"], "ref_urls": ["http://europepmc.org/abstract/MED/33054456", "https://cancerres.aacrjournals.org/content/80/22/4986"]}, {"gene_symbol": "FGFR3", "therapy_name": "Infigratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA", "Other", "PubMed"], "ref_ids": ["label/2021/214622s000lbl.pdf", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "21936542"], "ref_urls": ["http://europepmc.org/abstract/MED/21936542", "http://www.novartisoncology.com/ct/pipelineDetails?compound=BGJ398&diseaseAcr=GBM", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Nintedanib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pazopanib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "FGFR3", "therapy_name": "Pemigatinib", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213736s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf"]}, {"gene_symbol": "FGFR3", "therapy_name": "Rogaratinib", "targets_moa": "Fibroblast growth factor receptor inhibitor", "ref_sources": ["DOI"], "ref_ids": ["10.1158/1538-7445.AM2014-1739"], "ref_urls": ["http://cancerres.aacrjournals.org/content/74/19_Supplement/1739"]}, {"gene_symbol": "FGFR3", "therapy_name": "Tyrosine Kinase Inhibitor", "targets_moa": "Fibroblast growth factor receptor 3 inhibitor", "ref_sources": ["ClinicalTrials", "PubMed"], "ref_ids": ["NCT01948297", "25169980"], "ref_urls": ["http://europepmc.org/abstract/MED/25169980", "https://www.clinicaltrials.gov/ct2/show/NCT01948297"]}], "id": "F3.1-000046-P3", "question": "Show treatments that target FGFR2 or FGFR3.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(g.symbol) = toLower('FGFR2')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR2'))\n  OR toLower(g.symbol) = toLower('FGFR3')\n  OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('FGFR3'))\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 26953.83313399998, "input_tokens": 224, "output_tokens": 332, "tokens_per_second": 12.317357547977474, "gold_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "generated_rows": [{"gene_symbol": "AURKA", "therapy_name": "Alisertib", "targets_moa": "Serine/threonine-protein kinase Aurora-A inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22016509"], "ref_urls": ["http://europepmc.org/abstract/MED/22016509"]}, {"gene_symbol": "AURKA", "therapy_name": "Tozasertib", "targets_moa": "Serine/threonine-protein kinase Aurora inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["14981513", "26345296"], "ref_urls": ["http://europepmc.org/abstract/MED/14981513", "http://europepmc.org/abstract/MED/26345296"]}], "id": "F4.2-000016-P2", "question": "Which drugs target biomarkers of resistance to Platinum Compound in Ovarian Serous Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Platinum Compound')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Platinum Compound'))\n  OR toLower(t1.name) CONTAINS toLower('Platinum Compound')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian' AND\n    toLower(rel.disease_name) CONTAINS 'serous' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Platinum Compound')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 23576.293529, "input_tokens": 219, "output_tokens": 300, "tokens_per_second": 12.724646460266763, "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Amuvatinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Avapritinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "C-Met Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Cediranib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Crenolanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://arogpharma.com/crenolanib", "22745105", "24623852"], "ref_urls": ["http://arogpharma.com/crenolanib", "http://europepmc.org/abstract/MED/22745105", "http://europepmc.org/abstract/MED/24623852"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Dovitinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Foretinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Linifanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["16648571", "17343372"], "ref_urls": ["http://europepmc.org/abstract/MED/16648571", "http://europepmc.org/abstract/MED/17343372"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Midostaurin", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Motesanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Nintedanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Pazopanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Quizartinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Ripretinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Sunitinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor | Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "TRK Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Vatalanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dasatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA"], "ref_ids": ["setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "label/2010/021986s7s8lbl.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e7f054c-7a27-4192-bd1c-6115d8be858f#section-13", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021986s7s8lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Amuvatinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Avapritinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "C-Met Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Cediranib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Crenolanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://arogpharma.com/crenolanib", "22745105", "24623852"], "ref_urls": ["http://arogpharma.com/crenolanib", "http://europepmc.org/abstract/MED/22745105", "http://europepmc.org/abstract/MED/24623852"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Dovitinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Foretinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Linifanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["16648571", "17343372"], "ref_urls": ["http://europepmc.org/abstract/MED/16648571", "http://europepmc.org/abstract/MED/17343372"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Midostaurin", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Motesanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Nintedanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2014/205832s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Pazopanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Quizartinib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Ripretinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Sunitinib", "targets_moa": "Platelet-derived growth factor receptor alpha inhibitor | Platelet-derived growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "TRK Inhibitor", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "PDGFRA", "therapy_name": "Vatalanib", "targets_moa": "Platelet-derived growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "id": "F4.2-000184-P3", "question": "Find therapies that target resistance genes for Imatinib in Melanoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Imatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Imatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Imatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Imatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 23554.627271999947, "input_tokens": 223, "output_tokens": 300, "tokens_per_second": 12.736350974087308, "gold_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "generated_rows": [{"gene_symbol": "BRAF", "therapy_name": "Agerafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"], "ref_urls": ["http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf", "http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "BRAF Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Belvarafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other"], "ref_ids": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"], "ref_urls": ["https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.2570", "https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3000"]}, {"gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=803beaaa-33f9-48cc-9a95-c2e887e095b4#nlm34090-1"]}, {"gene_symbol": "BRAF", "therapy_name": "Encorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["DOI", "PubMed"], "ref_ids": ["10.1158/1538-7445.AM2012-3790", "23617957"], "ref_urls": ["http://cancerres.aacrjournals.org/content/72/8_Supplement/3790", "http://europepmc.org/abstract/MED/23617957"]}, {"gene_symbol": "BRAF", "therapy_name": "Pan-RAF Inhibitor LY3009120", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["25965804"], "ref_urls": ["http://europepmc.org/abstract/MED/25965804"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "TRK Inhibitor", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "BRAF", "therapy_name": "Tovorafenib", "targets_moa": "RAF serine/threonine protein kinase inhibitor", "ref_sources": ["Other", "Other", "PubMed"], "ref_ids": ["http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php", "5653214"], "ref_urls": ["http://europepmc.org/abstract/MED/5653214", "http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=710688", "http://www.sunesis.com/products-in-development/product/MLN2480.php"]}, {"gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "targets_moa": "Serine/threonine-protein kinase B-raf inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/202429s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202429s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Amuvatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed", "PubMed"], "ref_ids": ["http://www.google.com/patents/US20080226747", "24326130", "25110867"], "ref_urls": ["http://europepmc.org/abstract/MED/24326130", "http://europepmc.org/abstract/MED/25110867", "http://www.google.com/patents/US20080226747"]}, {"gene_symbol": "KIT", "therapy_name": "Avapritinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/212608s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "C-Met Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Cediranib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15899831"], "ref_urls": ["http://europepmc.org/abstract/MED/15899831"]}, {"gene_symbol": "KIT", "therapy_name": "Dovitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["15897558"], "ref_urls": ["http://europepmc.org/abstract/MED/15897558"]}, {"gene_symbol": "KIT", "therapy_name": "Foretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "PubMed"], "ref_ids": ["http://www.exelixis.com/pipeline/xl880", "19808973"], "ref_urls": ["http://europepmc.org/abstract/MED/19808973", "http://www.exelixis.com/pipeline/xl880"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "FDA", "Wikipedia"], "ref_ids": ["setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "label/2008/021588s024lbl.pdf", "Bcr-Abl_tyrosine-kinase_inhibitor"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b#section-13", "http://en.wikipedia.org/wiki/Bcr-Abl_tyrosine-kinase_inhibitor", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021588s024lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Midostaurin", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12124173", "16969355"], "ref_urls": ["http://europepmc.org/abstract/MED/12124173", "http://europepmc.org/abstract/MED/16969355"]}, {"gene_symbol": "KIT", "therapy_name": "Motesanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["16951187"], "ref_urls": ["http://europepmc.org/abstract/MED/16951187"]}, {"gene_symbol": "KIT", "therapy_name": "Pazopanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553#section-14"]}, {"gene_symbol": "KIT", "therapy_name": "Pexidartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2019/211810s000lbl.pdf", "22039576", "25847190"], "ref_urls": ["http://europepmc.org/abstract/MED/22039576", "http://europepmc.org/abstract/MED/25847190", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Quizartinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["19654408", "23497317"], "ref_urls": ["http://europepmc.org/abstract/MED/19654408", "http://europepmc.org/abstract/MED/23497317"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Regorafenib Anhydrous", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sorafenib Tosylate", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2011/021923s012lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021923s012lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Sunitinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["DailyMed", "EMA"], "ref_ids": ["setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c#section-14", "https://www.ema.europa.eu/en/documents/product-information/sunitinib-accord-epar-product-information_en.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "TRK Inhibitor", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"gene_symbol": "KIT", "therapy_name": "Tandutinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["Other", "Other", "PubMed", "PubMed"], "ref_ids": ["http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804", "12124172", "12166950"], "ref_urls": ["http://europepmc.org/abstract/MED/12124172", "http://europepmc.org/abstract/MED/12166950", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804", "http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804ayForward?objectId=1804"]}, {"gene_symbol": "KIT", "therapy_name": "Vatalanib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["10786682", "16882767"], "ref_urls": ["http://europepmc.org/abstract/MED/10786682", "http://europepmc.org/abstract/MED/16882767"]}], "id": "F4.2-000171-S1-P2", "question": "Which drugs target biomarkers of resistance to Dasatinib in Naevocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Gemcitabine')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n  OR toLower(t1.name) CONTAINS toLower('Gemcitabine')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Gemcitabine')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 25433.295164000014, "input_tokens": 226, "output_tokens": 323, "tokens_per_second": 12.69988799788695, "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "id": "F4.2-000042-P3", "question": "Find therapies that target resistance genes for Gemcitabine in Pancreatic Adenocarcinoma.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Gemcitabine')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Gemcitabine'))\n  OR toLower(t1.name) CONTAINS toLower('Gemcitabine')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Gemcitabine')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 17937.425384999984, "input_tokens": 223, "output_tokens": 227, "tokens_per_second": 12.65510490651723, "gold_rows": [{"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}, {"variant_name": "MET D1010N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26892698"]}, {"variant_name": "MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442"]}, {"variant_name": "MET Exon 14 Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31932802", "31416808"]}, {"variant_name": "MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["35679833", "31584608", "123413", "26892698"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31055074"]}, {"variant_name": "MET MET::ATXN7L1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30339198"]}, {"variant_name": "NOT MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "NOT", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27693535"]}, {"variant_name": "ROS1 G2032R", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157", "26372962"]}, {"variant_name": "ROS1 G2101A AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 S1986F", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "27401242"]}, {"variant_name": "ROS1 S1986Y", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "NTRK3 G623R AND EML4::NTRK3 Fusion", "gene_symbol": "NTRK3", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28183697"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30413378"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26554404"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ROS1 G2032R AND v::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 S1986Y/F", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "generated_rows": [{"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21575866"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "EGFR C797S", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EGFR T790M", "gene_symbol": "EGFR", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28287083"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Brigatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Brigatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534", "25736571", "24675041"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "ALK S1206Y AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24670165"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202del", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27432227"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK F1174C", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK F1174L", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21030459"]}, {"variant_name": "ALK F1174V", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24736079"]}, {"variant_name": "ALK G1202R AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23729361"]}, {"variant_name": "ALK G1269A AND EML4::ALK e6::e19 AND ALK Amplification", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23434628"]}, {"variant_name": "ALK I1171", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393798", "24675041", "25228534"]}, {"variant_name": "ALK I1171N AND HIP1::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "ALK L1152P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041"]}, {"variant_name": "ALK L1198F", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ALK L1198P", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21948233"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": "EGFR L858R", "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "21258415", "22912387"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK Amplification", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "23434628", "24675041", "22235099"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK F1245C", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26775591"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1269A", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171S", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25393796"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1152R", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21791641"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "21948233"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK S1206Y", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK T1151dup", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784", "24675041"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK V1180L", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25228534"]}, {"variant_name": "EML4 EML4::ALK e20::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "EML4 EML4::ALK e2::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["18927303"]}, {"variant_name": "EML4 EML4::ALK e6::e20", "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["20979469", "22912387"]}, {"variant_name": "KIF5B KIF5B::MET Fusion", "gene_symbol": "KIF5B", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29102694"]}, {"variant_name": "KRAS Amplification", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474"]}, {"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "KRAS G12V", "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": "MDM2 Amplification AND MET D1010H", "gene_symbol": "MDM2", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25898965"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31584608", "21623265", "27664533", "21716144"]}, {"variant_name": "MET Amplification AND MET Splice Site (c.3028G>A)", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26729443"]}, {"variant_name": "MET D1010N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26892698"]}, {"variant_name": "MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442"]}, {"variant_name": "MET Exon 14 Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31932802", "31416808"]}, {"variant_name": "MET Exon 14 Skipping Mutation", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["35679833", "31584608", "123413", "26892698"]}, {"variant_name": "MET Exon 14 Skipping Mutation AND MET D1228N", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31055074"]}, {"variant_name": "MET MET::ATXN7L1 Fusion", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30339198"]}, {"variant_name": "NOT MET Amplification AND MET Exon 14 Skipping Mutation", "gene_symbol": "NOT", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27693535"]}, {"variant_name": "ROS1 G2032R", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242"]}, {"variant_name": "ROS1 G2032R AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157", "26372962"]}, {"variant_name": "ROS1 G2101A AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 L2155S AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": "ROS1 S1986F", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "27401242"]}, {"variant_name": "ROS1 S1986Y", "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}, {"variant_name": "ALK G1269A AND v::ALK Fusion", "gene_symbol": "ALK", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Ensartinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31628085"]}, {"variant_name": "EML4 EML4::NTRK3 Fusion", "gene_symbol": "EML4", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "NTRK3 G623R AND EML4::NTRK3 Fusion", "gene_symbol": "NTRK3", "therapy_name": "Entrectinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["34625502"]}, {"variant_name": "SQSTM1 SQSTM1::NTRK1 Fusion", "gene_symbol": "SQSTM1", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["28183697"]}, {"variant_name": "ALK Mutation", "gene_symbol": "ALK", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30413378"]}, {"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26554404"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29650534"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910"]}, {"variant_name": "ROS1 G2032R AND v::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 L2026M AND CD74::ROS1 Fusion", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25733882"]}, {"variant_name": "ROS1 S1986Y/F", "gene_symbol": "ROS1", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27401242"]}, {"variant_name": "ABCB1 Overexpression", "gene_symbol": "ABCB1", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "id": "F4.1-000033-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Non-small Cell Lung Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 18857.67685899998, "input_tokens": 223, "output_tokens": 228, "tokens_per_second": 12.090566706852076, "gold_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "generated_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}], "id": "F4.1-000047-P1", "question": "What drugs targeting ALK have biomarker evidence in Diffuse Large B-cell Lymphoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'gastrointestinal' AND\n    toLower(rel.disease_name) CONTAINS 'stromal' AND\n    toLower(rel.disease_name) CONTAINS 'tumor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16943.25187300001, "input_tokens": 227, "output_tokens": 213, "tokens_per_second": 12.571376592673278, "gold_rows": [{"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Gastrointestinal Stromal Tumor", "pmids": ["40900786"]}], "generated_rows": [{"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Gastrointestinal Stromal Tumor", "pmids": ["40900786"]}], "id": "F4.1-000072-S1-P3", "question": "Show treatments hitting ALK that have biomarker evidence in Stromal Tumour Of Gastrointestinal Tract.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'gastrointestinal' AND\n    toLower(rel.disease_name) CONTAINS 'stromal' AND\n    toLower(rel.disease_name) CONTAINS 'tumor'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 14743.78084, "input_tokens": 222, "output_tokens": 182, "tokens_per_second": 12.344187829096896, "gold_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "generated_rows": [{"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}], "id": "F4.1-000096", "question": "Which therapies target ALK and also have biomarker evidence in Glioblastoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ALK')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ALK'))\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(bg:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE bg.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'SMARCB1 Deletion'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Tazemetostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tazemetostat'))\n  OR toLower(t.name) CONTAINS toLower('Tazemetostat')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'epithelioid' AND\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16385.39604099992, "input_tokens": 228, "output_tokens": 203, "tokens_per_second": 12.38908107512621, "gold_rows": [{"variant_name": "SMARCB1 Deletion", "gene_symbol": "SMARCB1", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Epithelioid Sarcoma", "pmids": ["33035459"]}], "generated_rows": [{"variant_name": "SMARCB1 Deletion", "gene_symbol": "SMARCB1", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Epithelioid Sarcoma", "pmids": ["33035459"]}], "id": "F2.2-000116-P3", "question": "How does SMARCB1 Deletion influence response to Tazemetostat for Epithelioid Sarcoma?", "gold_cypher": "MATCH (v:Variant {name: 'SMARCB1 Deletion'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Tazemetostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tazemetostat'))\n  OR toLower(t.name) CONTAINS toLower('Tazemetostat')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'epithelioid' AND\n    toLower(rel.disease_name) CONTAINS 'sarcoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16220.259489, "input_tokens": 235, "output_tokens": 202, "tokens_per_second": 12.453561555965807, "gold_rows": [{"variant_name": "RPS6 PHOSPHORYLATION", "gene_symbol": "RPS6", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Gastric Adenocarcinoma", "pmids": ["22343617"]}], "generated_rows": [], "id": "F2.2-000185-S1", "question": "How does the variant RPS6 PHOSPHORYLATION affect response to Everolimus in Adenocarcinoma Of Stomach?", "gold_cypher": "MATCH (v:Variant {name: 'RPS6 PHOSPHORYLATION'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'RET G810S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selpercatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib'))\n  OR toLower(t.name) CONTAINS toLower('Selpercatinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'medullary' AND\n    toLower(rel.disease_name) CONTAINS 'thyroid' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 17968.19511800004, "input_tokens": 233, "output_tokens": 219, "tokens_per_second": 12.188202463396664, "gold_rows": [{"variant_name": "RET G810S", "gene_symbol": "RET", "therapy_name": "Selpercatinib", "effect": "resistance", "disease_name": "Medullary Thyroid Carcinoma", "pmids": ["33161056"]}], "generated_rows": [{"variant_name": "RET G810S", "gene_symbol": "RET", "therapy_name": "Selpercatinib", "effect": "resistance", "disease_name": "Medullary Thyroid Carcinoma", "pmids": ["33161056"]}], "id": "F2.2-000010-S1-P1", "question": "What is the effect of RET G810S on Selpercatinib in Thyroid Gland Medullary Carcinoma?", "gold_cypher": "MATCH (v:Variant {name: 'RET G810S'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Selpercatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Selpercatinib'))\n  OR toLower(t.name) CONTAINS toLower('Selpercatinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'medullary' AND\n    toLower(rel.disease_name) CONTAINS 'thyroid' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'TP53 Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Eprenetapopt')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Eprenetapopt'))\n  OR toLower(t.name) CONTAINS toLower('Eprenetapopt')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 14744.751032999942, "input_tokens": 224, "output_tokens": 183, "tokens_per_second": 12.411196336271209, "gold_rows": [{"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["36084396"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Ovarian Cancer", "pmids": ["26086967"]}], "generated_rows": [{"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["36084396"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Eprenetapopt", "effect": "sensitivity", "disease_name": "Ovarian Cancer", "pmids": ["26086967"]}], "id": "F2.2-000017-S1-P2", "question": "Does TP53 Mutation predict response to Eprenetapopt in Malignant Tumor?", "gold_cypher": "MATCH (v:Variant {name: 'TP53 Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Eprenetapopt')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Eprenetapopt'))\n  OR toLower(t.name) CONTAINS toLower('Eprenetapopt')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'cancer'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'BRAF Wildtype'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100", "error": null, "latency_ms": 3634.757646999901, "input_tokens": 215, "output_tokens": 46, "tokens_per_second": 12.655589303998855, "gold_rows": [{"gene_symbol": "BRAF", "variant_name": "BRAF Wildtype"}], "generated_rows": [{"gene_symbol": "BRAF", "variant_name": "BRAF Wildtype"}], "id": "F1.3-000028", "question": "Which gene is BRAF Wildtype a variant of?", "gold_cypher": "MATCH (v:Variant {name: 'BRAF Wildtype'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100", "error": null, "latency_ms": 11185.363045000031, "input_tokens": 307, "output_tokens": 139, "tokens_per_second": 12.42695471222406, "gold_rows": [{"gene_symbol": "PIK3CA", "variant_name": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T"}], "generated_rows": [{"gene_symbol": "PIK3CA", "variant_name": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T"}], "id": "F1.3-000120-P1", "question": "PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T belongs to which gene?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L OR PIK3CA H1047D OR PIK3CA H1047I OR PIK3CA H1047N OR PIK3CA H1047P OR PIK3CA H1047Q OR PIK3CA H1047T'})-[:VARIANT_OF]->(g:Gene)\nRETURN g.symbol AS gene_symbol, v.name AS variant_name\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Erlotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Erlotinib'))\n  OR toLower(t.name) CONTAINS toLower('Erlotinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 20135.447189000046, "input_tokens": 219, "output_tokens": 251, "tokens_per_second": 12.465578620827491, "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["24353160", "23371856", "16407879", "26096453", "22895145", "26773740", "27032107", "23470965", "17085664", "19010870"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006", "17877814", "17085664", "24353160", "19147750", "19786660", "21841502", "25668228", "27304188", "15737014"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Acinar Adenocarcinoma", "pmids": ["23181703"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["16818618"]}, {"variant_name": null, "gene_symbol": "FGFR4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["31027687"]}, {"variant_name": null, "gene_symbol": "GNAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24758907"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15696205", "22982650", "24351425", "21969500", "22025157"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["19794967"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["16043828", "2199829"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "NRG1", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["27304188"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21258250"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["24353160", "23371856", "16407879", "26096453", "22895145", "26773740", "27032107", "23470965", "17085664", "19010870"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21132006", "17877814", "17085664", "24353160", "19147750", "19786660", "21841502", "25668228", "27304188", "15737014"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Acinar Adenocarcinoma", "pmids": ["23181703"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["16818618"]}, {"variant_name": null, "gene_symbol": "FGFR4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["31027687"]}, {"variant_name": null, "gene_symbol": "GNAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24758907"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["15696205", "22982650", "24351425", "21969500", "22025157"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["19794967"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Cancer", "pmids": ["16043828", "2199829"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["23470965"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22773810"]}, {"variant_name": null, "gene_symbol": "NRG1", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26418897"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Adenocarcinoma", "pmids": ["27304188"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21258250"]}], "id": "F2.2-000180-P3", "question": "What genes are resistance biomarkers for Erlotinib in Lung Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Erlotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Erlotinib'))\n  OR toLower(t.name) CONTAINS toLower('Erlotinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Foretinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Foretinib'))\n  OR toLower(t.name) CONTAINS toLower('Foretinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 23209.30221499998, "input_tokens": 223, "output_tokens": 293, "tokens_per_second": 12.624248557142597, "gold_rows": [{"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Foretinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Foretinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}], "id": "F2.2-000101-P3", "question": "What genes are resistance biomarkers for Foretinib in Lung Non-small Cell Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Foretinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Foretinib'))\n  OR toLower(t.name) CONTAINS toLower('Foretinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Docetaxel')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Docetaxel'))\n  OR toLower(t.name) CONTAINS toLower('Docetaxel')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 19532.48328799998, "input_tokens": 219, "output_tokens": 250, "tokens_per_second": 12.799191803409379, "gold_rows": [{"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Stomach Cancer", "pmids": ["24088382"]}], "id": "F2.2-000165", "question": "Which genes predict resistance to Docetaxel in Stomach Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Docetaxel')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Docetaxel'))\n  OR toLower(t.name) CONTAINS toLower('Docetaxel')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'stomach'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 22620.052860999975, "input_tokens": 226, "output_tokens": 288, "tokens_per_second": 12.732065736970531, "gold_rows": [{"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "id": "F2.2-000166-P2", "question": "List genes associated with resistance to Imatinib Mesylate in Acute Myeloid Leukemia.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100", "error": null, "latency_ms": 4285.674803000006, "input_tokens": 222, "output_tokens": 48, "tokens_per_second": 11.200103182443899, "gold_rows": [{"variant_name": "VHL c.340+770T>C", "variant_consequence": null}], "generated_rows": [{"variant_name": "VHL c.340+770T>C", "variant_consequence": null}], "id": "F2.4-000056-P2", "question": "Report the consequence for VHL c.340+770T>C.", "gold_cypher": "MATCH (v:Variant {name: 'VHL c.340+770T>C'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'EGFR R705K'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100", "error": null, "latency_ms": 3256.7076220000217, "input_tokens": 219, "output_tokens": 42, "tokens_per_second": 12.896460129327421, "gold_rows": [{"variant_name": "EGFR R705K", "variant_consequence": null}], "generated_rows": [{"variant_name": "EGFR R705K", "variant_consequence": null}], "id": "F2.4-000035", "question": "What is the consequence of the EGFR R705K variant?", "gold_cypher": "MATCH (v:Variant {name: 'EGFR R705K'})\nRETURN\n  v.name AS variant_name,\n  v.consequence AS variant_consequence\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 23712.57005999996, "input_tokens": 229, "output_tokens": 299, "tokens_per_second": 12.609345981622393, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000012-S1-P3", "question": "Show treatments for TOP1 excluding HDAC1 that have biomarker evidence in Ureteral Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('HDAC1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('HDAC1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 23978.719821000028, "input_tokens": 230, "output_tokens": 299, "tokens_per_second": 12.469389618462554, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000094", "question": "What therapies target TOP1 but NOT PSMA1, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMA1')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMA1'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('SRD5A3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('SRD5A3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 23871.056554000006, "input_tokens": 228, "output_tokens": 303, "tokens_per_second": 12.693196018138842, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000027-P1", "question": "Which drugs hit TOP1 but not SRD5A3 with evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('SRD5A3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('SRD5A3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 23782.10740700001, "input_tokens": 228, "output_tokens": 299, "tokens_per_second": 12.57247706786458, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000167-P3", "question": "Show treatments for TOP1 excluding POLD3 that have biomarker evidence in Ureter Small Cell Carcinoma.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'pleural' AND\n    toLower(rel.disease_name) CONTAINS 'mesothelioma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 11728.025864999949, "input_tokens": 221, "output_tokens": 147, "tokens_per_second": 12.534078769274666, "gold_rows": [{"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "BAP1 Mutation", "gene_symbol": "BAP1", "therapy_name": "CDK4/6 Inhibition", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["34588615"]}, {"variant_name": "MDM2 EXPRESSION", "gene_symbol": "MDM2", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["25668009"]}, {"variant_name": "BAP1 Loss", "gene_symbol": "BAP1", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["26437366"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "MDM2 EXPRESSION", "gene_symbol": "MDM2", "therapy_name": "Pemetrexed", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["25668009"]}], "generated_rows": [{"variant_name": "EML4 EML4::ALK Fusion", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Alectinib", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "BAP1 Mutation", "gene_symbol": "BAP1", "therapy_name": "CDK4/6 Inhibition", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["34588615"]}, {"variant_name": "MDM2 EXPRESSION", "gene_symbol": "MDM2", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["25668009"]}, {"variant_name": "BAP1 Loss", "gene_symbol": "BAP1", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["26437366"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK G1202R AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "EML4 EML4::ALK Fusion AND ALK I1171N AND ALK L1196M", "gene_symbol": "EML4", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["32600123"]}, {"variant_name": "MDM2 EXPRESSION", "gene_symbol": "MDM2", "therapy_name": "Pemetrexed", "effect": "resistance", "disease_name": "Malignant Pleural Mesothelioma", "pmids": ["25668009"]}], "id": "F5.2-000017-P3", "question": "List treatments supported by variant evidence in Malignant Pleural Mesothelioma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'pleural' AND\n    toLower(rel.disease_name) CONTAINS 'mesothelioma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 't-cell' AND\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoblastic' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 12791.666621999979, "input_tokens": 223, "output_tokens": 162, "tokens_per_second": 12.664495158229139, "gold_rows": [{"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NOTCH1 F1592C", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 F1592S", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1585R", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 Mutation", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577A", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577E", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "MTOR C1483Y", "gene_symbol": "MTOR", "therapy_name": "Sirolimus", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["24631838"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "JAK3 M511I", "gene_symbol": "JAK3", "therapy_name": "Tofacitinib", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["25193870"]}], "generated_rows": [{"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Arabinosylguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Mercaptopurine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Nelarabine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NOTCH1 F1592C", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 F1592S", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1574Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1585R", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600P", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 L1600Q", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 Mutation", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577A", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "NOTCH1 V1577E", "gene_symbol": "NOTCH1", "therapy_name": "Prednisone", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["16614245"]}, {"variant_name": "MTOR C1483Y", "gene_symbol": "MTOR", "therapy_name": "Sirolimus", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["24631838"]}, {"variant_name": "NT5C2 D407A", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 K359Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "NT5C2 R367Q", "gene_symbol": "NT5C2", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["23377281"]}, {"variant_name": "JAK3 M511I", "gene_symbol": "JAK3", "therapy_name": "Tofacitinib", "effect": "sensitivity", "disease_name": "T-cell Acute Lymphoblastic Leukemia", "pmids": ["25193870"]}], "id": "F5.2-000096-P2", "question": "Show drugs with variant-based evidence in T-cell Acute Lymphoblastic Leukemia.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 't-cell' AND\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoblastic' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma' AND\n    toLower(rel.disease_name) CONTAINS 'of' AND\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 15958.991183999955, "input_tokens": 222, "output_tokens": 204, "tokens_per_second": 12.782762873164865, "gold_rows": [{"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Afatinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25892145"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Alisertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "HRAS G12V", "gene_symbol": "HRAS", "therapy_name": "Alpelisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30115483"]}, {"variant_name": "PIK3CA E542K", "gene_symbol": "PIK3CA", "therapy_name": "Apitolisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26787751"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Aspirin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Barasertib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Celecoxib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577089"]}, {"variant_name": "EGF EXPRESSION", "gene_symbol": "EGF", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25677871"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039", "27207775"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR P546S", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23578570"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "NRAS G13V", "gene_symbol": "NRAS", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28259104"]}, {"variant_name": "SMAD4 Underexpression", "gene_symbol": "SMAD4", "therapy_name": "Cetuximab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26046389"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "KRAS RS61764370", "gene_symbol": "KRAS", "therapy_name": "Cisplatin", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25081901"]}, {"variant_name": "AURKB Overexpression", "gene_symbol": "AURKB", "therapy_name": "Copanlisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["36169922"]}, {"variant_name": "AREG Expression", "gene_symbol": "AREG", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Docetaxel", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21653686"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24577117"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB2 S1050L", "gene_symbol": "ERBB2", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB3 R1202W", "gene_symbol": "ERBB3", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "ERBB4 G1109C", "gene_symbol": "ERBB4", "therapy_name": "Erlotinib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["27207775"]}, {"variant_name": "MAPK1 E278E", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029"]}, {"variant_name": "MAPK1 E322K", "gene_symbol": "MAPK1", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26181029", "27004400"]}, {"variant_name": "CDKN1B EXPRESSION", "gene_symbol": "CDKN1B", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24239278"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Fluorouracil", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Ibuprofen", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "FGFR1 Expression", "gene_symbol": "FGFR1", "therapy_name": "Infigratinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26015511"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "JSI-124", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "ERBB2 Overexpression", "gene_symbol": "ERBB2", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28061634"]}, {"variant_name": "NRG1 Expression", "gene_symbol": "NRG1", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21840482"]}, {"variant_name": "DPYD EXON 11-19 DELETION", "gene_symbol": "DPYD", "therapy_name": "Leucovorin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["31871216"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "CDKN2A p16 Expression", "gene_symbol": "CDKN2A", "therapy_name": "Panitumumab", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23746666"]}, {"variant_name": "FGFR2 P253R", "gene_symbol": "FGFR2", "therapy_name": "Pazopanib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["23786770"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Platinum Compound", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["21048039"]}, {"variant_name": "NOTCH1 Loss-of-function", "gene_symbol": "NOTCH1", "therapy_name": "Porcupine Inhibitor WNT974", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["24277854"]}, {"variant_name": "CD274 Expression", "gene_symbol": "CD274", "therapy_name": "Radiation Therapy", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["28476872"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Radiation Therapy", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTPRT Promoter Hypermethylation", "gene_symbol": "PTPRT", "therapy_name": "Stattic", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["25982282"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Sulindac", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["30683736"]}, {"variant_name": "PIK3CA Amplification", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA H1047R", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Taselisib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Taselisib", "effect": "resistance", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26589432"]}, {"variant_name": "HRAS Mutation", "gene_symbol": "HRAS", "therapy_name": "Tipifarnib", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["33750196"]}, {"variant_name": "ALDH1A2 Underexpression", "gene_symbol": "ALDH1A2", "therapy_name": "Tretinoin", "effect": "sensitivity", "disease_name": "Head And Neck Squamous Cell Carcinoma", "pmids": ["26634247"]}], "generated_rows": [], "id": "F5.2-000015-S1-P1", "question": "Which therapies have variant biomarkers in Squamous Cell Carcinomas Of Head And Neck?", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'head' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'neck' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 12715.776326999958, "input_tokens": 221, "output_tokens": 160, "tokens_per_second": 12.58279446613614, "gold_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["21494621"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584"]}, {"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35380993"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "PIM1 L2V", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 P81S", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 S97N", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "MS4A1 Mutation", "gene_symbol": "MS4A1", "therapy_name": "R-CHOP Regimen", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32589730"]}, {"variant_name": "TMEM30A loss-of-function mutation", "gene_symbol": "TMEM30A", "therapy_name": "R-CHOP Regimen", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32094924"]}, {"variant_name": "EZH2 Y646H", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29650362"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584", "28835384"]}, {"variant_name": "EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["34159682"]}, {"variant_name": "EZH2 expression", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma Germinal Center B-cell Type", "pmids": ["33492746"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Venetoclax", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29463802"]}], "generated_rows": [{"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "ALK Inhibitor TAE684", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["21494621"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Atezolizumab", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584"]}, {"variant_name": "CLTC CLTC::ALK Fusion", "gene_symbol": "CLTC", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["26221234"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "EPZ011989", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35380993"]}, {"variant_name": "EZH2 Y646F", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "GSK126", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["23051747"]}, {"variant_name": "PIM1 L2V", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 P81S", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "PIM1 S97N", "gene_symbol": "PIM1", "therapy_name": "Ibrutinib", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma Activated B-cell Type", "pmids": ["27904766"]}, {"variant_name": "MS4A1 Mutation", "gene_symbol": "MS4A1", "therapy_name": "R-CHOP Regimen", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32589730"]}, {"variant_name": "TMEM30A loss-of-function mutation", "gene_symbol": "TMEM30A", "therapy_name": "R-CHOP Regimen", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["32094924"]}, {"variant_name": "EZH2 Y646H", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29650362"]}, {"variant_name": "EZH2 Y646N", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["35151584", "28835384"]}, {"variant_name": "EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["34159682"]}, {"variant_name": "EZH2 expression", "gene_symbol": "EZH2", "therapy_name": "Tazemetostat", "effect": "sensitivity", "disease_name": "Diffuse Large B-cell Lymphoma Germinal Center B-cell Type", "pmids": ["33492746"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Venetoclax", "effect": "resistance", "disease_name": "Diffuse Large B-cell Lymphoma", "pmids": ["29463802"]}], "id": "F5.2-000082", "question": "List therapies with variant-level biomarkers in Diffuse Large B-cell Lymphoma.", "gold_cypher": "MATCH (v:Variant)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'diffuse' AND\n    toLower(rel.disease_name) CONTAINS 'large' AND\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (v)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PXDNL P1460T'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pembrolizumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pembrolizumab'))\n  OR toLower(t.name) CONTAINS toLower('Pembrolizumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16954.67814999995, "input_tokens": 232, "output_tokens": 209, "tokens_per_second": 12.326981270358154, "gold_rows": [{"variant_name": "PXDNL P1460T", "gene_symbol": "PXDNL", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["25765070"]}], "generated_rows": [{"variant_name": "PXDNL P1460T", "gene_symbol": "PXDNL", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Lung Adenocarcinoma", "pmids": ["25765070"]}], "id": "F2.2-000074-P3", "question": "How does PXDNL P1460T influence response to Pembrolizumab for Lung Adenocarcinoma?", "gold_cypher": "MATCH (v:Variant {name: 'PXDNL P1460T'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pembrolizumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pembrolizumab'))\n  OR toLower(t.name) CONTAINS toLower('Pembrolizumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'KRAS Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Refametinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Refametinib'))\n  OR toLower(t.name) CONTAINS toLower('Refametinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 14437.241578999987, "input_tokens": 223, "output_tokens": 183, "tokens_per_second": 12.675551558698496, "gold_rows": [{"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Refametinib", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["23434733"]}], "generated_rows": [{"variant_name": "KRAS Mutation", "gene_symbol": "KRAS", "therapy_name": "Refametinib", "effect": "sensitivity", "disease_name": "Colorectal Cancer", "pmids": ["23434733"]}], "id": "F2.2-000200-P3", "question": "How does KRAS Mutation influence response to Refametinib for Colorectal Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'KRAS Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Refametinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Refametinib'))\n  OR toLower(t.name) CONTAINS toLower('Refametinib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'colorectal'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 14423.616733000017, "input_tokens": 224, "output_tokens": 181, "tokens_per_second": 12.548863669254834, "gold_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "generated_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "id": "F2.2-000159", "question": "How does the variant PIK3CA Mutation affect response to Ribociclib in Breast Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 14494.406503999926, "input_tokens": 221, "output_tokens": 181, "tokens_per_second": 12.487575807264038, "gold_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "generated_rows": [{"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Ribociclib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["25002028"]}], "id": "F2.2-000159-P2", "question": "Does PIK3CA Mutation predict response to Ribociclib in Breast Cancer?", "gold_cypher": "MATCH (v:Variant {name: 'PIK3CA Mutation'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ribociclib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ribociclib'))\n  OR toLower(t.name) CONTAINS toLower('Ribociclib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP2A')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP2A'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16427.966172999957, "input_tokens": 224, "output_tokens": 207, "tokens_per_second": 12.600464221810554, "gold_rows": [], "generated_rows": [], "id": "F6.3-000117-S1-P3", "question": "Show therapies for TOP2A where variants cause resistance in Acute Myelogenous Leukemia.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TOP2A')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TOP2A'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ABL1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'chronic' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16048.756767999976, "input_tokens": 223, "output_tokens": 206, "tokens_per_second": 12.83588523260248, "gold_rows": [{"variant_name": "ABL1 F486Y", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "19075254"]}, {"variant_name": "ABL1 L298V", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "ABL1 Non-P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 C475V", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19779040"]}, {"variant_name": "ABL1 V379I", "gene_symbol": "ABL1", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298"]}, {"variant_name": "ABL1 K356dup", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22713161"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "ABL1 Double Ph", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "ABL1 C475V", "gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Nilotinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056"]}], "generated_rows": [{"variant_name": "ABL1 F486Y", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878", "19075254"]}, {"variant_name": "ABL1 L298V", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346"]}, {"variant_name": "ABL1 Non-P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["21865346", "22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 C475V", "gene_symbol": "ABL1", "therapy_name": "Bosutinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19779040"]}, {"variant_name": "ABL1 V379I", "gene_symbol": "ABL1", "therapy_name": "Dasatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["17264298"]}, {"variant_name": "ABL1 K356dup", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22713161"]}, {"variant_name": "ABL1 P-Loop Mutation", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "ABL1 Double Ph", "gene_symbol": "ABL1", "therapy_name": "Imatinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["12623848"]}, {"variant_name": "ABL1 C475V", "gene_symbol": "ABL1", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["22371878"]}, {"variant_name": "ABL1 TKD Mutation", "gene_symbol": "ABL1", "therapy_name": "Nilotinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["19652056"]}], "id": "F6.3-000102-P3", "question": "Show therapies for ABL1 where variants cause resistance in Chronic Myeloid Leukemia.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('ABL1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ABL1'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'chronic' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('KIT')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KIT'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16244.484680999904, "input_tokens": 223, "output_tokens": 203, "tokens_per_second": 12.496549074125795, "gold_rows": [{"variant_name": "KIT D816H", "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "generated_rows": [{"variant_name": "KIT D816H", "gene_symbol": "KIT", "therapy_name": "Imatinib Mesylate", "effect": "resistance", "disease_name": "Acute Myeloid Leukemia", "pmids": ["15650049"]}], "id": "F6.3-000178-P3", "question": "Show therapies for KIT where variants cause resistance in Acute Myeloid Leukemia.", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('KIT')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KIT'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 15371.974841999872, "input_tokens": 225, "output_tokens": 194, "tokens_per_second": 12.620369340570745, "gold_rows": [], "generated_rows": [], "id": "F6.3-000155-P1", "question": "Which therapies targeting POLD3 have variant-level resistance in Pancreatic Adenocarcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('POLD3')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('POLD3'))\nMATCH (v:Variant)-[:VARIANT_OF]->(g)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'pancreatic' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TUBA3C')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TUBA3C'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 10470.369778000077, "input_tokens": 213, "output_tokens": 130, "tokens_per_second": 12.415989383025499, "gold_rows": [{"therapy_name": "Cabazitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "Taxane"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "http://en.wikipedia.org/wiki/Taxane"]}, {"therapy_name": "Docetaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["FDA", "Wikipedia"], "ref_ids": ["label/2014/201195s006lbl.pdf", "Microtubule"], "ref_urls": ["http://en.wikipedia.org/wiki/Microtubule", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf"]}, {"therapy_name": "Enfortumab Vedotin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["Other", "PubMed", "PubMed", "PubMed"], "ref_ids": ["http://www.seattlegenetics.com/pipeline/enfortumab-vedotin", "27013195", "27518442", "28353637"], "ref_urls": ["http://europepmc.org/abstract/MED/27013195", "http://europepmc.org/abstract/MED/27518442", "http://europepmc.org/abstract/MED/28353637", "http://www.seattlegenetics.com/pipeline/enfortumab-vedotin"]}, {"therapy_name": "Eribulin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "22619477"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "http://europepmc.org/abstract/MED/22619477"]}, {"therapy_name": "Paclitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Taxol", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Trastuzumab Emtansine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "DailyMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "1241159", "22044006", "23798344"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "http://europepmc.org/abstract/MED/1241159", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/23798344"]}, {"therapy_name": "Vincristine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "22044006"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "http://europepmc.org/abstract/MED/22044006"]}, {"therapy_name": "Vinorelbine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "22044006", "22594474"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/22594474"]}], "generated_rows": [{"therapy_name": "Cabazitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "Taxane"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa#nlm34090-1", "http://en.wikipedia.org/wiki/Taxane"]}, {"therapy_name": "Docetaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["FDA", "Wikipedia"], "ref_ids": ["label/2014/201195s006lbl.pdf", "Microtubule"], "ref_urls": ["http://en.wikipedia.org/wiki/Microtubule", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201195s006lbl.pdf"]}, {"therapy_name": "Enfortumab Vedotin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["Other", "PubMed", "PubMed", "PubMed"], "ref_ids": ["http://www.seattlegenetics.com/pipeline/enfortumab-vedotin", "27013195", "27518442", "28353637"], "ref_urls": ["http://europepmc.org/abstract/MED/27013195", "http://europepmc.org/abstract/MED/27518442", "http://europepmc.org/abstract/MED/28353637", "http://www.seattlegenetics.com/pipeline/enfortumab-vedotin"]}, {"therapy_name": "Eribulin", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "22619477"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ce4750-ded5-4a0b-95e9-f229fa6bc822#nlm34090-1", "http://europepmc.org/abstract/MED/22619477"]}, {"therapy_name": "Paclitaxel", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Taxol", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "Microtubule"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d10449-2936-4cd3-b7db-a7683db721e4#section-15", "http://en.wikipedia.org/wiki/Microtubule"]}, {"therapy_name": "Trastuzumab Emtansine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "DailyMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "1241159", "22044006", "23798344"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e", "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23f3c1f4-0fc8-4804-a9e3-04cf25dd302e#nlm34090-1", "http://europepmc.org/abstract/MED/1241159", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/23798344"]}, {"therapy_name": "Vincristine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "22044006"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9", "http://europepmc.org/abstract/MED/22044006"]}, {"therapy_name": "Vinorelbine", "gene_symbol": "TUBA3C", "targets_moa": "Tubulin inhibitor", "ref_sources": ["DailyMed", "PubMed", "PubMed"], "ref_ids": ["setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "22044006", "22594474"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6d47c96a-7fdc-48ac-9250-41c5d3ecf8db", "http://europepmc.org/abstract/MED/22044006", "http://europepmc.org/abstract/MED/22594474"]}], "id": "F1.1-000036-P1", "question": "Which therapies target TUBA3C?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('TUBA3C')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('TUBA3C'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('DDR2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('DDR2'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 9675.09992600003, "input_tokens": 213, "output_tokens": 124, "tokens_per_second": 12.81640509642418, "gold_rows": [{"therapy_name": "Regorafenib", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"therapy_name": "Regorafenib Anhydrous", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"therapy_name": "TRK Inhibitor", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}], "generated_rows": [{"therapy_name": "Regorafenib", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"therapy_name": "Regorafenib Anhydrous", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}, {"therapy_name": "TRK Inhibitor", "gene_symbol": "DDR2", "targets_moa": "Discoidin domain-containing receptor 2 inhibitor", "ref_sources": ["Expert", "FDA"], "ref_ids": ["REGORAFENIB", "label/2012/203085lbl.pdf"], "ref_urls": ["http://chembl.blogspot.co.uk/search?q=REGORAFENIB", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203085lbl.pdf"]}], "id": "F1.1-000156-P3", "question": "What medications are known to target DDR2?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('DDR2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('DDR2'))\nRETURN\n  t.name AS therapy_name,\n  g.symbol AS gene_symbol,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Ripretinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ripretinib'))\n  OR toLower(t.name) CONTAINS toLower('Ripretinib')\n)\n  AND (\n    toLower(g.symbol) = toLower('KIT')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KIT'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 15216.535701000112, "input_tokens": 215, "output_tokens": 191, "tokens_per_second": 12.552134319735238, "gold_rows": [{"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "KIT", "therapy_name": "Ripretinib", "targets_moa": "Stem cell growth factor receptor inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2020/213973s000lbl.pdf"], "ref_urls": ["http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf"]}], "id": "F2.1-000090-P2", "question": "Describe how Ripretinib acts on KIT.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Ripretinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ripretinib'))\n  OR toLower(t.name) CONTAINS toLower('Ripretinib')\n)\n  AND (\n    toLower(g.symbol) = toLower('KIT')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('KIT'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Afimoxifene')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Afimoxifene'))\n  OR toLower(t.name) CONTAINS toLower('Afimoxifene')\n)\n  AND (\n    toLower(g.symbol) = toLower('ESRRG')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ESRRG'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 15356.262089999973, "input_tokens": 220, "output_tokens": 195, "tokens_per_second": 12.698402700940118, "gold_rows": [{"gene_symbol": "ESRRG", "therapy_name": "Afimoxifene", "targets_moa": "Estrogen-related receptor gamma antagonist", "ref_sources": ["KEGG", "PubMed", "Wikipedia"], "ref_ids": ["D06551", "11447273", "Afimoxifene"], "ref_urls": ["http://en.wikipedia.org/wiki/Afimoxifene", "http://europepmc.org/abstract/MED/11447273"]}], "generated_rows": [{"gene_symbol": "ESRRG", "therapy_name": "Afimoxifene", "targets_moa": "Estrogen-related receptor gamma antagonist", "ref_sources": ["KEGG", "PubMed", "Wikipedia"], "ref_ids": ["D06551", "11447273", "Afimoxifene"], "ref_urls": ["http://en.wikipedia.org/wiki/Afimoxifene", "http://europepmc.org/abstract/MED/11447273"]}], "id": "F2.1-000095-P1", "question": "What is the MOA of Afimoxifene on ESRRG?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Afimoxifene')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Afimoxifene'))\n  OR toLower(t.name) CONTAINS toLower('Afimoxifene')\n)\n  AND (\n    toLower(g.symbol) = toLower('ESRRG')\n    OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('ESRRG'))\n  )\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 10918.630553999947, "input_tokens": 216, "output_tokens": 134, "tokens_per_second": 12.272601342932173, "gold_rows": [{"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "3-Dimensional Conformal Radiation Therapy", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Adavosertib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification AND EGFR EGFRVIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26423602"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR EGFR::WIF1 Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "IDH-wildtype Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "VEGFA Overexpression", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["18182667"]}, {"variant_name": "VEGFA Overexpression of VEGF121", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["29747600"]}, {"variant_name": "EGFR EGFR::VSTM2A Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab/Lomustine Regimen", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PIK3R1 Mutation", "gene_symbol": "PIK3R1", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Carmustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "IDH1 R132", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "IDH1 R132S", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Dacomitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25939761"]}, {"variant_name": "DRD5 low expression", "gene_symbol": "DRD5", "therapy_name": "Dordaviprone", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30559168"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "FGFR1 FGFR1::TACC1 Fusion", "gene_symbol": "FGFR1", "therapy_name": "Futibatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34551969"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "ROS1 Overexpression", "gene_symbol": "ROS1", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25978031"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "KANK1 KANK1::NTRK2 Fusion", "gene_symbol": "KANK1", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34041811"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25730903"]}, {"variant_name": "HGF EXPRESSION", "gene_symbol": "HGF", "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22203985"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "Navtemadlin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Nimotuzumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "PMS2 K706FS*19", "gene_symbol": "PMS2", "therapy_name": "Nivolumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27001570"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Nivolumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "O6-Benzylguanine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "CDK6 Amplification", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "CDK6 Overexpression", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma Proneural Subtype", "pmids": ["28903422"]}, {"variant_name": "CDKN2A Loss", "gene_symbol": "CDKN2A", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22711607"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "IDH1 R132H", "gene_symbol": "IDH1", "therapy_name": "Pan-Mutant-IDH1 Inhibitor Bay-1436032", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21045145"]}, {"variant_name": "POLE Mutation", "gene_symbol": "POLE", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27683556"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Pembrolizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Pexidartinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Pyridostatin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Rindopepimut", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25586468"]}, {"variant_name": "KIT EXPRESSION", "gene_symbol": "KIT", "therapy_name": "Sunitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24311637"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31852834"]}, {"variant_name": "ATM Mutation", "gene_symbol": "ATM", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23960094"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "MGMT RS16906252", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25910840"]}, {"variant_name": "MGMT Underexpression", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21331613"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Vatalanib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24725538"]}], "generated_rows": [{"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "3-Dimensional Conformal Radiation Therapy", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Adavosertib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification AND EGFR EGFRVIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26423602"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Afatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR EGFR::WIF1 Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "IDH-wildtype Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "VEGFA Overexpression", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["18182667"]}, {"variant_name": "VEGFA Overexpression of VEGF121", "gene_symbol": "VEGFA", "therapy_name": "Bevacizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["29747600"]}, {"variant_name": "EGFR EGFR::VSTM2A Fusion", "gene_symbol": "EGFR", "therapy_name": "Bevacizumab/Lomustine Regimen", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "PIK3CA Mutation", "gene_symbol": "PIK3CA", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PIK3R1 Mutation", "gene_symbol": "PIK3R1", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Buparlisib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30715997"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Carmustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "IDH1 R132", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "IDH1 R132S", "gene_symbol": "IDH1", "therapy_name": "Cetuximab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22199315"]}, {"variant_name": "ALK Expression", "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26498130"]}, {"variant_name": "MET Amplification", "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22162573"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Dacomitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25939761"]}, {"variant_name": "DRD5 low expression", "gene_symbol": "DRD5", "therapy_name": "Dordaviprone", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30559168"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Dovitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BCR BCR::NTRK2 Fusion", "gene_symbol": "BCR", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Brain Glioblastoma Multiforme", "pmids": ["35673607"]}, {"variant_name": "ETV6 ETV6::NTRK3 Fusion", "gene_symbol": "ETV6", "therapy_name": "Entrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["35395680"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Erlotinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "FGFR1 FGFR1::TACC1 Fusion", "gene_symbol": "FGFR1", "therapy_name": "Futibatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34551969"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "PTEN Expression", "gene_symbol": "PTEN", "therapy_name": "Gefitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["16282176"]}, {"variant_name": "ROS1 Overexpression", "gene_symbol": "ROS1", "therapy_name": "Gefitinib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25978031"]}, {"variant_name": "EGFR EGFR::SEPTIN14 Fusion", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23917401"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Lapatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "KANK1 KANK1::NTRK2 Fusion", "gene_symbol": "KANK1", "therapy_name": "Larotrectinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34041811"]}, {"variant_name": "EGFR Overexpression", "gene_symbol": "EGFR", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["26762204"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Lomustine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "GOPC GOPC::ROS1 e7::e35", "gene_symbol": "GOPC", "therapy_name": "Lorlatinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30171048"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "MDM2 Inhibitor AMGMDS3", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["25730903"]}, {"variant_name": "HGF EXPRESSION", "gene_symbol": "HGF", "therapy_name": "MET Tyrosine Kinase Inhibitor SGX523", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22203985"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "Navtemadlin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Nimotuzumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "PMS2 K706FS*19", "gene_symbol": "PMS2", "therapy_name": "Nivolumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27001570"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Nivolumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "O6-Benzylguanine", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["11070098"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Olaparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Osimertinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR G598V", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Pacritinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32226941"]}, {"variant_name": "CDK6 Amplification", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "CDK6 Overexpression", "gene_symbol": "CDK6", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma Proneural Subtype", "pmids": ["28903422"]}, {"variant_name": "CDKN2A Loss", "gene_symbol": "CDKN2A", "therapy_name": "Palbociclib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["22711607"]}, {"variant_name": "RB1 Loss-of-function", "gene_symbol": "RB1", "therapy_name": "Palbociclib", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["20354191"]}, {"variant_name": "IDH1 R132H", "gene_symbol": "IDH1", "therapy_name": "Pan-Mutant-IDH1 Inhibitor Bay-1436032", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21045145"]}, {"variant_name": "POLE Mutation", "gene_symbol": "POLE", "therapy_name": "Pembrolizumab", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["27683556"]}, {"variant_name": "PTEN Mutation", "gene_symbol": "PTEN", "therapy_name": "Pembrolizumab", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["30742119"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Pexidartinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Pyridostatin", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "MDM2 Amplification", "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}, {"variant_name": "EGFR VIII", "gene_symbol": "EGFR", "therapy_name": "Rindopepimut", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25586468"]}, {"variant_name": "KIT EXPRESSION", "gene_symbol": "KIT", "therapy_name": "Sunitinib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24311637"]}, {"variant_name": "ATRX Loss-of-function", "gene_symbol": "ATRX", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["34118569"]}, {"variant_name": "EGFR Amplification", "gene_symbol": "EGFR", "therapy_name": "Talazoparib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31852834"]}, {"variant_name": "ATM Mutation", "gene_symbol": "ATM", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["23960094"]}, {"variant_name": "BRCA2 K3326*", "gene_symbol": "BRCA2", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["32043779"]}, {"variant_name": "EGFR Expression", "gene_symbol": "EGFR", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["31289592"]}, {"variant_name": "MGMT Promoter Methylation", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30782343"]}, {"variant_name": "MGMT RS16906252", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["25910840"]}, {"variant_name": "MGMT Underexpression", "gene_symbol": "MGMT", "therapy_name": "Temozolomide", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["21331613"]}, {"variant_name": "TP53 M237I", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 Mutation", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "TP53 R273H", "gene_symbol": "TP53", "therapy_name": "Temozolomide", "effect": "resistance", "disease_name": "Glioblastoma", "pmids": ["24248532"]}, {"variant_name": "CSF1R Expression", "gene_symbol": "CSF1R", "therapy_name": "Vatalanib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["28759044"]}, {"variant_name": "BRAF V600E", "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["24725538"]}], "id": "F5.1-000158-P1", "question": "Which biomarkers show evidence in Glioblastoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'anal' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 12098.092638000026, "input_tokens": 220, "output_tokens": 148, "tokens_per_second": 12.23333333844155, "gold_rows": [{"variant_name": "KIT Internal Duplication", "gene_symbol": "KIT", "therapy_name": "Imatinib", "effect": "sensitivity", "disease_name": "Malignant Anus Melanoma", "pmids": ["18421059"]}], "generated_rows": [], "id": "F5.1-000175", "question": "In Malignant Anus Melanoma, which biomarkers have evidence?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'malignant' AND\n    toLower(rel.disease_name) CONTAINS 'anus' AND\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'non-hodgkin' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 13486.549776999937, "input_tokens": 223, "output_tokens": 168, "tokens_per_second": 12.456855369081014, "gold_rows": [{"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}, {"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Galiximab", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}], "generated_rows": [{"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Cisplatin", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}, {"variant_name": "CD80 Overexpression", "gene_symbol": "CD80", "therapy_name": "Galiximab", "effect": "sensitivity", "disease_name": "B-cell Non-Hodgkin Lymphoma", "pmids": ["22267549"]}], "id": "F5.1-000018-P3", "question": "What biomarkers have therapy response evidence in B-cell Non-Hodgkin Lymphoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'b-cell' AND\n    toLower(rel.disease_name) CONTAINS 'non-hodgkin' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 25254.93518400003, "input_tokens": 229, "output_tokens": 315, "tokens_per_second": 12.472809678781697, "gold_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24055054", "25452114", "23237741"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25452114", "24265153"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23171796"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "25452114"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "AEBP1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24201813"]}, {"variant_name": null, "gene_symbol": "AGK", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23890088"]}, {"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24265152"]}, {"variant_name": null, "gene_symbol": "AKT3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "26070258", "25515853", "24112705", "24055054", "24576830", "22113612"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "CIC", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["21107323"]}, {"variant_name": null, "gene_symbol": "GNAQ", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24504448"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21383288", "23569304", "24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["26359985", "23802768"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23288408", "23171796"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23288408"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "23569304", "21107323", "22395615", "20149136", "28783719"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23948972", "22194965"]}, {"variant_name": null, "gene_symbol": "PAPSS1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24345920"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PIK3R2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PREX2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "RAF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27273450"]}, {"variant_name": null, "gene_symbol": "SOX10", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24670642"]}, {"variant_name": null, "gene_symbol": "STAG2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "STAG3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "TF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "TRIM24", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24345920"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24055054", "25452114", "23237741"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["25452114", "24265153"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23171796"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "25452114"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Dabrafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "AEBP1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24201813"]}, {"variant_name": null, "gene_symbol": "AGK", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23890088"]}, {"variant_name": null, "gene_symbol": "AKT1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "24265152"]}, {"variant_name": null, "gene_symbol": "AKT3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "ATXN1L", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "26070258", "25515853", "24112705", "24055054", "24576830", "22113612"]}, {"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23237741"]}, {"variant_name": null, "gene_symbol": "CDKN2A", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "CIC", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["28178529"]}, {"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["21107323"]}, {"variant_name": null, "gene_symbol": "GNAQ", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24504448"]}, {"variant_name": null, "gene_symbol": "HOXD8", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "MAP2K1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["21383288", "23569304", "24265153"]}, {"variant_name": null, "gene_symbol": "MAP2K2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["26359985", "23802768"]}, {"variant_name": null, "gene_symbol": "MITF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23288408", "23171796"]}, {"variant_name": null, "gene_symbol": "NF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["23288408"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155", "23569304", "21107323", "22395615", "20149136", "28783719"]}, {"variant_name": null, "gene_symbol": "NRAS", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["23948972", "22194965"]}, {"variant_name": null, "gene_symbol": "PAPSS1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24345920"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PIK3R2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PREX2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "RAC1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265153", "25056119"]}, {"variant_name": null, "gene_symbol": "RAF1", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27273450"]}, {"variant_name": null, "gene_symbol": "SOX10", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24670642"]}, {"variant_name": null, "gene_symbol": "STAG2", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "STAG3", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["27500726"]}, {"variant_name": null, "gene_symbol": "TF", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Melanoma", "pmids": ["24265155"]}, {"variant_name": null, "gene_symbol": "TRIM24", "therapy_name": "Vemurafenib", "effect": "resistance", "disease_name": "Skin Melanoma", "pmids": ["24345920"]}], "id": "F6.1-000125-S1-P1", "question": "In Naevocarcinoma, which genes confer resistance to Vemurafenib or Dabrafenib?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR toLower(t.name) = toLower('Dabrafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dabrafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n  OR toLower(t.name) CONTAINS toLower('Dabrafenib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'melanoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ceritinib')\n  OR toLower(t.name) = toLower('ALK Inhibitor TAE684')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ceritinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('ALK Inhibitor TAE684'))\n  OR toLower(t.name) CONTAINS toLower('Ceritinib')\n  OR toLower(t.name) CONTAINS toLower('ALK Inhibitor TAE684')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 30295.794230999945, "input_tokens": 233, "output_tokens": 370, "tokens_per_second": 12.21291632689399, "gold_rows": [{"variant_name": null, "gene_symbol": "EML4", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "24675041", "27432227"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": null, "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "EML4", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22277784"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "ALK Inhibitor TAE684", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["25688157"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26698910", "24675041", "27432227"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26372962"]}, {"variant_name": null, "gene_symbol": "ABCB1", "therapy_name": "Ceritinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "id": "F6.1-000024-P1", "question": "In Lung Non-small Cell Carcinoma, which genes confer resistance to Ceritinib or ALK Inhibitor TAE684?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ceritinib')\n  OR toLower(t.name) = toLower('ALK Inhibitor TAE684')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ceritinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('ALK Inhibitor TAE684'))\n  OR toLower(t.name) CONTAINS toLower('Ceritinib')\n  OR toLower(t.name) CONTAINS toLower('ALK Inhibitor TAE684')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Platinum Doublet')\n  OR toLower(t.name) = toLower('Dacomitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Platinum Doublet'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dacomitinib'))\n  OR toLower(t.name) CONTAINS toLower('Platinum Doublet')\n  OR toLower(t.name) CONTAINS toLower('Dacomitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 28809.01819299993, "input_tokens": 223, "output_tokens": 355, "tokens_per_second": 12.322530314006277, "gold_rows": [{"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": null, "gene_symbol": "NFE2L2", "therapy_name": "Platinum Doublet", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31548347"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Dacomitinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["21430269"]}, {"variant_name": null, "gene_symbol": "NFE2L2", "therapy_name": "Platinum Doublet", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["31548347"]}], "id": "F6.1-000014-S1-P2", "question": "List resistance genes for Platinum Doublet or Dacomitinib in Non-small Cell Lung Cancer.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Platinum Doublet')\n  OR toLower(t.name) = toLower('Dacomitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Platinum Doublet'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Dacomitinib'))\n  OR toLower(t.name) CONTAINS toLower('Platinum Doublet')\n  OR toLower(t.name) CONTAINS toLower('Dacomitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Crizotinib')\n  OR toLower(t.name) = toLower('Cabozantinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Crizotinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Cabozantinib'))\n  OR toLower(t.name) CONTAINS toLower('Crizotinib')\n  OR toLower(t.name) CONTAINS toLower('Cabozantinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 28850.78148299999, "input_tokens": 230, "output_tokens": 361, "tokens_per_second": 12.512659326497458, "gold_rows": [{"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Cabozantinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27496134"]}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041", "21030459", "24736079", "23729361", "22235099", "23434628", "25393798", "25228534", "25393796", "21948233"]}, {"variant_name": null, "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "26698910", "23434628", "24675041", "26775591", "25393796", "21791641", "21948233", "25228534"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474", "22235099"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442", "31055074"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242", "26372962"]}, {"variant_name": null, "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "KIF5B", "therapy_name": "Cabozantinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27496134"]}, {"variant_name": null, "gene_symbol": "ALK", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["24675041", "21030459", "24736079", "23729361", "22235099", "23434628", "25393798", "25228534", "25393796", "21948233"]}, {"variant_name": null, "gene_symbol": "AREG", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["23344087", "21791641"]}, {"variant_name": null, "gene_symbol": "EGFR", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099"]}, {"variant_name": null, "gene_symbol": "EML4", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["22235099", "23344087", "22277784", "26698910", "23434628", "24675041", "26775591", "25393796", "21791641", "21948233", "25228534"]}, {"variant_name": null, "gene_symbol": "KRAS", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["30072474", "22235099"]}, {"variant_name": null, "gene_symbol": "MET", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["27343442", "31055074"]}, {"variant_name": null, "gene_symbol": "ROS1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["29333528", "25688157", "27401242", "26372962"]}, {"variant_name": null, "gene_symbol": "ABCB1", "therapy_name": "Crizotinib", "effect": "resistance", "disease_name": "Lung Non-small Cell Carcinoma", "pmids": ["26870817"]}], "id": "F6.1-000049-S1-P1", "question": "In Non-small Cell Lung Carcinoma, which genes confer resistance to Crizotinib or Cabozantinib?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Crizotinib')\n  OR toLower(t.name) = toLower('Cabozantinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Crizotinib'))\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Cabozantinib'))\n  OR toLower(t.name) CONTAINS toLower('Crizotinib')\n  OR toLower(t.name) CONTAINS toLower('Cabozantinib')\n)\nAND toLower(rel.effect) = 'resistance'\nAND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'resistance' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'eosinophilia' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'abnormalities' AND\n    toLower(rel.disease_name) CONTAINS 'of' AND\n    toLower(rel.disease_name) CONTAINS 'platelet-derived' AND\n    toLower(rel.disease_name) CONTAINS 'growth' AND\n    toLower(rel.disease_name) CONTAINS 'factor' AND\n    toLower(rel.disease_name) CONTAINS 'receptor' AND\n    toLower(rel.disease_name) CONTAINS 'alpha' AND\n    toLower(rel.disease_name) CONTAINS 'or' AND\n    toLower(rel.disease_name) CONTAINS 'platelet-derived' AND\n    toLower(rel.disease_name) CONTAINS 'growth' AND\n    toLower(rel.disease_name) CONTAINS 'factor' AND\n    toLower(rel.disease_name) CONTAINS 'receptor' AND\n    toLower(rel.disease_name) CONTAINS 'beta' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'fibroblast' AND\n    toLower(rel.disease_name) CONTAINS 'growth' AND\n    toLower(rel.disease_name) CONTAINS 'factor' AND\n    toLower(rel.disease_name) CONTAINS 'receptor-1' AND\n    toLower(rel.disease_name) CONTAINS 'are' AND\n    toLower(rel.disease_name) CONTAINS 'a' AND\n    toLower(rel.disease_name) CONTAINS 'group' AND\n    toLower(rel.disease_name) CONTAINS 'of' AND\n    toLower(rel.disease_name) CONTAINS 'hematologic' AND\n    toLower(rel.disease_name) CONTAINS 'neoplasms'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 56700.009050000066, "input_tokens": 294, "output_tokens": 693, "tokens_per_second": 12.222220271409272, "gold_rows": [], "generated_rows": [], "id": "F6.4-000195-S1", "question": "For resistance to Dasatinib in Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of Platelet-derived Growth Factor Receptor Alpha (PDGFRA), Platelet-derived Growth Factor Receptor Beta (PDGFRB), And Fibroblast Growth Factor Receptor-1 (FGFR1) Are A Group Of Hematologic Neoplasms, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Dasatinib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Dasatinib'))\n  OR toLower(t1.name) CONTAINS toLower('Dasatinib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'lymphoid' AND\n    toLower(rel.disease_name) CONTAINS 'neoplasms' AND\n    toLower(rel.disease_name) CONTAINS 'with' AND\n    toLower(rel.disease_name) CONTAINS 'eosinophilia' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'abnormalities' AND\n    toLower(rel.disease_name) CONTAINS 'of' AND\n    toLower(rel.disease_name) CONTAINS 'pdgfra,' AND\n    toLower(rel.disease_name) CONTAINS 'pdgfrb,' AND\n    toLower(rel.disease_name) CONTAINS 'and' AND\n    toLower(rel.disease_name) CONTAINS 'fgfr1'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Dasatinib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Pemetrexed')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Pemetrexed'))\n  OR toLower(t1.name) CONTAINS toLower('Pemetrexed')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Pemetrexed')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 30174.790206000125, "input_tokens": 224, "output_tokens": 350, "tokens_per_second": 11.599086443040258, "gold_rows": [{"gene_symbol": "TYMS", "therapy_name": "Capecitabine", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Fluorouracil", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Raltitrexed", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12056700", "9579851"], "ref_urls": ["http://europepmc.org/abstract/MED/12056700", "http://europepmc.org/abstract/MED/9579851"]}, {"gene_symbol": "TYMS", "therapy_name": "Tegafur", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["EMA"], "ref_ids": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"], "ref_urls": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"]}], "generated_rows": [{"gene_symbol": "TYMS", "therapy_name": "Capecitabine", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8#section-13", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Fluorouracil", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["DailyMed", "PubMed"], "ref_ids": ["setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "12724731"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac", "http://europepmc.org/abstract/MED/12724731"]}, {"gene_symbol": "TYMS", "therapy_name": "Raltitrexed", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["PubMed", "PubMed"], "ref_ids": ["12056700", "9579851"], "ref_urls": ["http://europepmc.org/abstract/MED/12056700", "http://europepmc.org/abstract/MED/9579851"]}, {"gene_symbol": "TYMS", "therapy_name": "Tegafur", "targets_moa": "Thymidylate synthase inhibitor", "ref_sources": ["EMA"], "ref_ids": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"], "ref_urls": ["https://www.ema.europa.eu/en/documents/product-information/teysuno-epar-product-information_en.pdf"]}], "id": "F6.4-000002-P2", "question": "Which treatments target resistance biomarkers for Pemetrexed in Lung Non-small Cell Carcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Pemetrexed')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Pemetrexed'))\n  OR toLower(t1.name) CONTAINS toLower('Pemetrexed')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Pemetrexed')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('MUC1-targeted Peptide GO-203-2C')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('MUC1-targeted Peptide GO-203-2C'))\n  OR toLower(t1.name) CONTAINS toLower('MUC1-targeted Peptide GO-203-2C')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('MUC1-targeted Peptide GO-203-2C')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 33041.7379449998, "input_tokens": 239, "output_tokens": 394, "tokens_per_second": 11.924312233691811, "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "id": "F6.4-000173-S1", "question": "For resistance to MUC1-targeted Peptide GO-203-2C in Non-small Cell Lung Carcinoma, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('MUC1-targeted Peptide GO-203-2C')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('MUC1-targeted Peptide GO-203-2C'))\n  OR toLower(t1.name) CONTAINS toLower('MUC1-targeted Peptide GO-203-2C')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'lung' AND\n    toLower(rel.disease_name) CONTAINS 'non-small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('MUC1-targeted Peptide GO-203-2C')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Cetuximab')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Cetuximab'))\n  OR toLower(t1.name) CONTAINS toLower('Cetuximab')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Cetuximab')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 26875.321693999922, "input_tokens": 226, "output_tokens": 307, "tokens_per_second": 11.423119079111883, "gold_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "generated_rows": [{"gene_symbol": "KRAS", "therapy_name": "Adagrasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["31658955"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/31658955/"]}, {"gene_symbol": "KRAS", "therapy_name": "Salirasib", "targets_moa": "RAS inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["22547163"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/22547163/"]}, {"gene_symbol": "KRAS", "therapy_name": "Sotorasib", "targets_moa": "GTPase KRas inhibitor", "ref_sources": ["PubMed", "PubMed", "PubMed", "PubMed"], "ref_ids": ["31189530", "31666701", "31820981", "32568546"], "ref_urls": ["http://europepmc.org/abstract/MED/31189530", "http://europepmc.org/abstract/MED/31666701", "http://europepmc.org/abstract/MED/31820981", "http://europepmc.org/abstract/MED/32568546"]}], "id": "F6.4-000094", "question": "For resistance to Cetuximab in Ovarian Cancer, which therapies target the resistance biomarkers?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Cetuximab')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Cetuximab'))\n  OR toLower(t1.name) CONTAINS toLower('Cetuximab')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'ovarian'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Cetuximab')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'ERBB2 Amplification'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Margetuximab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Margetuximab'))\n  OR toLower(t.name) CONTAINS toLower('Margetuximab')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 15057.92798099992, "input_tokens": 224, "output_tokens": 179, "tokens_per_second": 11.88742569534547, "gold_rows": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Margetuximab", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["33480963"]}], "generated_rows": [{"variant_name": "ERBB2 Amplification", "gene_symbol": "ERBB2", "therapy_name": "Margetuximab", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["33480963"]}], "id": "F2.3-000195", "question": "Provide PMIDs supporting that ERBB2 Amplification confers sensitivity to Margetuximab.", "gold_cypher": "MATCH (v:Variant {name: 'ERBB2 Amplification'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Margetuximab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Margetuximab'))\n  OR toLower(t.name) CONTAINS toLower('Margetuximab')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'KRAS G12C'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 17630.519927000023, "input_tokens": 234, "output_tokens": 210, "tokens_per_second": 11.911163191415492, "gold_rows": [{"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26739882"]}], "generated_rows": [{"variant_name": "KRAS G12C", "gene_symbol": "KRAS", "therapy_name": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor", "effect": "sensitivity", "disease_name": "Cancer", "pmids": ["26739882"]}], "id": "F2.3-000182-P2", "question": "What PubMed IDs support sensitivity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor due to KRAS G12C?", "gold_cypher": "MATCH (v:Variant {name: 'KRAS G12C'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor'))\n  OR toLower(t.name) CONTAINS toLower('Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor')\n)\nAND toLower(rel.effect) = 'sensitivity'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'sensitivity' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Mocetinostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Mocetinostat'))\n  OR toLower(t.name) CONTAINS toLower('Mocetinostat')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 22236.9942360001, "input_tokens": 220, "output_tokens": 255, "tokens_per_second": 11.467377168591126, "gold_rows": [{"variant_name": null, "gene_symbol": "HDAC2", "therapy_name": "Mocetinostat", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["28560068"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "HDAC2", "therapy_name": "Mocetinostat", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["28560068"]}], "id": "F2.2-000147-P2", "question": "List genes associated with sensitivity to Mocetinostat in Breast Cancer.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Mocetinostat')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Mocetinostat'))\n  OR toLower(t.name) CONTAINS toLower('Mocetinostat')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ponatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ponatinib'))\n  OR toLower(t.name) CONTAINS toLower('Ponatinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 23688.11444899984, "input_tokens": 225, "output_tokens": 282, "tokens_per_second": 11.904704386967643, "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR1OP2", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FIP1L1", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060", "21482694", "23430109"]}, {"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "FGFR1OP2", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FIP1L1", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}, {"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060", "21482694", "23430109"]}, {"variant_name": null, "gene_symbol": "KIT", "therapy_name": "Ponatinib", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["21482694"]}], "id": "F2.2-000187-S2-P3", "question": "What genes are sensitivity biomarkers for Ponatinib in Acute Myeloblastic Leukaemia?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Ponatinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Ponatinib'))\n  OR toLower(t.name) CONTAINS toLower('Ponatinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 20945.08090000022, "input_tokens": 226, "output_tokens": 252, "tokens_per_second": 12.03146462900496, "gold_rows": [{"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22802530"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058", "23888070"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["22802530"]}, {"variant_name": null, "gene_symbol": "ERBB2", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PIK3CA", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058", "23888070"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["20453058"]}, {"variant_name": null, "gene_symbol": "PTEN", "therapy_name": "Pictilisib", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["20453058"]}], "id": "F2.2-000019-S1-P3", "question": "What genes are sensitivity biomarkers for Pictilisib in Malignant Neoplasm Of Breast?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Pictilisib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Pictilisib'))\n  OR toLower(t.name) CONTAINS toLower('Pictilisib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('RG7112')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('RG7112'))\n  OR toLower(t.name) CONTAINS toLower('RG7112')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 21902.012535000038, "input_tokens": 221, "output_tokens": 254, "tokens_per_second": 11.597107781492719, "gold_rows": [{"variant_name": null, "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MDM2", "therapy_name": "RG7112", "effect": "sensitivity", "disease_name": "Glioblastoma", "pmids": ["30022047"]}], "id": "F2.2-000054", "question": "Which genes predict sensitivity to RG7112 in Glioblastoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('RG7112')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('RG7112'))\n  OR toLower(t.name) CONTAINS toLower('RG7112')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'glioblastoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Onartuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Onartuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Onartuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 21796.587455999997, "input_tokens": 225, "output_tokens": 258, "tokens_per_second": 11.836715289529405, "gold_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": null, "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MET", "therapy_name": "Onartuzumab", "effect": null, "disease_name": "Gastric Adenocarcinoma", "pmids": ["22389872"]}], "id": "F2.2-000095", "question": "Which genes affect response to Onartuzumab in Gastric Adenocarcinoma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Onartuzumab')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Onartuzumab'))\n  OR toLower(t.name) CONTAINS toLower('Onartuzumab')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'gastric' AND\n    toLower(rel.disease_name) CONTAINS 'adenocarcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Chemotherapy')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Chemotherapy'))\n  OR toLower(t.name) CONTAINS toLower('Chemotherapy')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 22357.021126000065, "input_tokens": 221, "output_tokens": 262, "tokens_per_second": 11.71891364790578, "gold_rows": [{"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Chemotherapy", "effect": null, "disease_name": "Acute Myeloid Leukemia", "pmids": ["28644114"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "FLT3", "therapy_name": "Chemotherapy", "effect": null, "disease_name": "Acute Myeloid Leukemia", "pmids": ["28644114"]}], "id": "F2.2-000134", "question": "Which genes affect response to Chemotherapy in Acute Myeloid Leukemia?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Chemotherapy')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Chemotherapy'))\n  OR toLower(t.name) CONTAINS toLower('Chemotherapy')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MTOR Kinase Inhibitor AZD8055')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MTOR Kinase Inhibitor AZD8055'))\n  OR toLower(t.name) CONTAINS toLower('MTOR Kinase Inhibitor AZD8055')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 22635.4918720001, "input_tokens": 226, "output_tokens": 262, "tokens_per_second": 11.574742951536725, "gold_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": null, "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "MTOR", "therapy_name": "MTOR Kinase Inhibitor AZD8055", "effect": null, "disease_name": "Breast Cancer", "pmids": ["27279227"]}], "id": "F2.2-000064-P2", "question": "Which genes influence response to MTOR Kinase Inhibitor AZD8055 for Breast Cancer?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('MTOR Kinase Inhibitor AZD8055')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('MTOR Kinase Inhibitor AZD8055'))\n  OR toLower(t.name) CONTAINS toLower('MTOR Kinase Inhibitor AZD8055')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": false, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'childhood' AND\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 21899.49664200003, "input_tokens": 222, "output_tokens": 257, "tokens_per_second": 11.735429548965596, "gold_rows": [{"variant_name": null, "gene_symbol": "BRAF", "therapy_name": "Vemurafenib", "effect": null, "disease_name": "Ganglioglioma", "pmids": ["26579623", "31985841", "30120137"]}], "generated_rows": [], "id": "F2.2-000038-S1-P2", "question": "Which genes influence response to Vemurafenib for Childhood Ganglioglioma?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Vemurafenib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Vemurafenib'))\n  OR toLower(t.name) CONTAINS toLower('Vemurafenib')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'ganglioglioma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('TUBA4A')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('TUBA4A'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 16482.10260099995, "input_tokens": 217, "output_tokens": 200, "tokens_per_second": 12.134374165821916, "gold_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "id": "F3.3-000140", "question": "Which drugs target TOP1 but not TUBA4A?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('TUBA4A')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('TUBA4A'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('EPHA3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('EPHA3'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 17770.25834999995, "input_tokens": 215, "output_tokens": 196, "tokens_per_second": 11.029665193359474, "gold_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "TOP1", "therapy_name": "7-Ethyl-10-Hydroxycamptothecin", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed", "Other"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af", "https://clincancerres.aacrjournals.org/content/clincanres/6/3/813.full.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Datopotamab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["Other"], "ref_ids": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"], "ref_urls": ["https://mct.aacrjournals.org/content/18/12_Supplement/C026"]}, {"gene_symbol": "TOP1", "therapy_name": "Irinotecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["DailyMed"], "ref_ids": ["setid=80f3b79c-a399-45b3-b755-8535457719af"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}, {"gene_symbol": "TOP1", "therapy_name": "Sacituzumab Govitecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA", "PubMed", "PubMed"], "ref_ids": ["label/2020/761115s000lbl.pdf", "28503956", "28558150"], "ref_urls": ["http://europepmc.org/abstract/MED/28503956", "http://europepmc.org/abstract/MED/28558150", "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf"]}, {"gene_symbol": "TOP1", "therapy_name": "Trastuzumab Deruxtecan", "targets_moa": "DNA topoisomerase I inhibitor", "ref_sources": ["FDA"], "ref_ids": ["label/2019/761139s000lbl.pdf"], "ref_urls": ["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf"]}], "id": "F3.3-000188-P2", "question": "List treatments targeting TOP1 and not EPHA3.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('EPHA3')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('EPHA3'))\nWITH t, r, gi, gx\nWHERE gx IS NULL\nRETURN\n  gi.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PDCD1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PDCD1'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100", "error": null, "latency_ms": 6674.010253999995, "input_tokens": 215, "output_tokens": 77, "tokens_per_second": 11.537291234134813, "gold_rows": [], "generated_rows": [], "id": "F1.4-000118-P4", "question": "Enumerate the variants linked to PDCD1.", "gold_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PDCD1')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PDCD1'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PARP2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PARP2'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100", "error": null, "latency_ms": 7088.981533999913, "input_tokens": 215, "output_tokens": 75, "tokens_per_second": 10.579799036051618, "gold_rows": [], "generated_rows": [], "id": "F1.4-000135", "question": "List all known variants of the PARP2 gene.", "gold_cypher": "MATCH (v:Variant)-[:VARIANT_OF]->(g:Gene)\nWHERE toLower(g.symbol) = toLower('PARP2')\n   OR any(s IN coalesce(g.synonyms, []) WHERE toLower(s) = toLower('PARP2'))\nRETURN v.name AS variant_name, g.symbol AS gene_symbol\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PRPS1 D183E'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Thioguanine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Thioguanine'))\n  OR toLower(t.name) CONTAINS toLower('Thioguanine')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 15297.586199999841, "input_tokens": 224, "output_tokens": 182, "tokens_per_second": 11.897301810922425, "gold_rows": [{"variant_name": "PRPS1 D183E", "gene_symbol": "PRPS1", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "B-lymphoblastic Leukemia/lymphoma", "pmids": ["25962120"]}], "generated_rows": [{"variant_name": "PRPS1 D183E", "gene_symbol": "PRPS1", "therapy_name": "Thioguanine", "effect": "resistance", "disease_name": "B-lymphoblastic Leukemia/lymphoma", "pmids": ["25962120"]}], "id": "F2.3-000121-P3", "question": "Give PMIDs for PRPS1 D183E-mediated resistance to Thioguanine.", "gold_cypher": "MATCH (v:Variant {name: 'PRPS1 D183E'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Thioguanine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Thioguanine'))\n  OR toLower(t.name) CONTAINS toLower('Thioguanine')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'BCR BCR::ABL1 Fusion AND ABL1 F311I'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Axitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Axitinib'))\n  OR toLower(t.name) CONTAINS toLower('Axitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16843.41514899984, "input_tokens": 234, "output_tokens": 188, "tokens_per_second": 11.161631909973043, "gold_rows": [{"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}], "generated_rows": [{"variant_name": "BCR BCR::ABL1 Fusion AND ABL1 F311I", "gene_symbol": "BCR", "therapy_name": "Axitinib", "effect": "resistance", "disease_name": "Chronic Myeloid Leukemia", "pmids": ["26582647"]}], "id": "F2.3-000165-P2", "question": "What PMIDs support resistance of Axitinib due to BCR BCR::ABL1 Fusion AND ABL1 F311I?", "gold_cypher": "MATCH (v:Variant {name: 'BCR BCR::ABL1 Fusion AND ABL1 F311I'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Axitinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Axitinib'))\n  OR toLower(t.name) CONTAINS toLower('Axitinib')\n)\nAND toLower(rel.effect) = 'resistance'\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  'resistance' AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Fedratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fedratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fedratinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 12950.280467000084, "input_tokens": 213, "output_tokens": 148, "tokens_per_second": 11.428323917550182, "gold_rows": [{"gene_symbol": "FLT3", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase receptor FLT3 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}, {"gene_symbol": "JAK2", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase JAK2 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}], "generated_rows": [{"gene_symbol": "FLT3", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase receptor FLT3 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}, {"gene_symbol": "JAK2", "therapy_name": "Fedratinib", "targets_moa": "Tyrosine-protein kinase JAK2 inhibitor", "ref_sources": ["FDA", "PubMed"], "ref_ids": ["label/2019/212327s000lbl.pdf", "18394554"], "ref_urls": ["http://europepmc.org/abstract/MED/18394554", "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf"]}], "id": "F1.2-000166-P2", "question": "List genes that Fedratinib targets.", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Fedratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fedratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fedratinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Decitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Decitabine'))\n  OR toLower(t.name) CONTAINS toLower('Decitabine')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 13132.837755000082, "input_tokens": 213, "output_tokens": 148, "tokens_per_second": 11.26946077923271, "gold_rows": [{"gene_symbol": "DNMT1", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 1 inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}, {"gene_symbol": "DNMT3A", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 3A inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}], "generated_rows": [{"gene_symbol": "DNMT1", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 1 inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}, {"gene_symbol": "DNMT3A", "therapy_name": "Decitabine", "targets_moa": "DNA (cytosine-5)-methyltransferase 3A inhibitor", "ref_sources": ["DailyMed", "Wikipedia"], "ref_ids": ["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "DNA_methylation"], "ref_urls": ["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13", "http://en.wikipedia.org/wiki/DNA_methylation"]}], "id": "F1.2-000035", "question": "Which genes does Decitabine target?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Decitabine')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Decitabine'))\n  OR toLower(t.name) CONTAINS toLower('Decitabine')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Fexagratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'cervical' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 26631.51229299979, "input_tokens": 230, "output_tokens": 301, "tokens_per_second": 11.302399829510215, "gold_rows": [{"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Fexagratinib", "effect": "sensitivity", "disease_name": "Cervical Squamous Cell Carcinoma", "pmids": ["32463741"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "FGFR3", "therapy_name": "Fexagratinib", "effect": "sensitivity", "disease_name": "Cervical Squamous Cell Carcinoma", "pmids": ["32463741"]}], "id": "F2.2-000112-S1", "question": "Which genes predict sensitivity to Fexagratinib in Squamous Cell Carcinoma Of The Cervix Uteri?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Fexagratinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Fexagratinib'))\n  OR toLower(t.name) CONTAINS toLower('Fexagratinib')\n)\nAND toLower(rel.effect) = 'sensitivity'\nAND (\n    toLower(rel.disease_name) CONTAINS 'cervical' AND\n    toLower(rel.disease_name) CONTAINS 'squamous' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  'sensitivity' AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('KDR')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('KDR'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 26157.45258400011, "input_tokens": 225, "output_tokens": 297, "tokens_per_second": 11.354316673087187, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000056-P1", "question": "Which drugs hit TOP1 but not KDR with evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('KDR')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('KDR'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'FLT3 S574'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Midostaurin')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Midostaurin'))\n  OR toLower(t.name) CONTAINS toLower('Midostaurin')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 19172.97114799999, "input_tokens": 230, "output_tokens": 216, "tokens_per_second": 11.265859544285176, "gold_rows": [{"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}], "generated_rows": [{"variant_name": "FLT3 S574", "gene_symbol": "FLT3", "therapy_name": "Midostaurin", "effect": "sensitivity", "disease_name": "Acute Myeloid Leukemia", "pmids": ["33914060"]}], "id": "F2.2-000095-P3", "question": "How does FLT3 S574 influence response to Midostaurin for Acute Myeloid Leukemia?", "gold_cypher": "MATCH (v:Variant {name: 'FLT3 S574'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Midostaurin')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Midostaurin'))\n  OR toLower(t.name) CONTAINS toLower('Midostaurin')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'acute' AND\n    toLower(rel.disease_name) CONTAINS 'myeloid' AND\n    toLower(rel.disease_name) CONTAINS 'leukemia'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'dermatofibrosarcoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100", "error": null, "latency_ms": 21285.68451299998, "input_tokens": 227, "output_tokens": 246, "tokens_per_second": 11.557063144939427, "gold_rows": [{"variant_name": null, "gene_symbol": "COL1A1", "therapy_name": "Imatinib Mesylate", "effect": null, "disease_name": "Dermatofibrosarcoma Protuberans", "pmids": ["20439456", "15681532", "10446987"]}, {"variant_name": null, "gene_symbol": "PDGFB", "therapy_name": "Imatinib Mesylate", "effect": null, "disease_name": "Dermatofibrosarcoma Protuberans", "pmids": ["19620561"]}], "generated_rows": [{"variant_name": null, "gene_symbol": "COL1A1", "therapy_name": "Imatinib Mesylate", "effect": null, "disease_name": "Dermatofibrosarcoma Protuberans", "pmids": ["20439456", "15681532", "10446987"]}, {"variant_name": null, "gene_symbol": "PDGFB", "therapy_name": "Imatinib Mesylate", "effect": null, "disease_name": "Dermatofibrosarcoma Protuberans", "pmids": ["19620561"]}], "id": "F2.2-000080-P2", "question": "Which genes influence response to Imatinib Mesylate for Dermatofibrosarcoma Protuberans?", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Imatinib Mesylate')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Imatinib Mesylate'))\n  OR toLower(t.name) CONTAINS toLower('Imatinib Mesylate')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'dermatofibrosarcoma' AND\n    toLower(rel.disease_name) CONTAINS 'protuberans'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nWHERE gene_symbol IS NOT NULL\nUNWIND pmids AS p\nWITH gene_symbol, therapy_name, disease_name, collect(DISTINCT p) AS pmids\nRETURN\n  NULL AS variant_name,\n  gene_symbol,\n  therapy_name,\n  NULL AS effect,\n  disease_name,\n  pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Capivasertib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Capivasertib'))\n  OR toLower(t1.name) CONTAINS toLower('Capivasertib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Capivasertib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 26112.55931000005, "input_tokens": 220, "output_tokens": 303, "tokens_per_second": 11.603611748771147, "gold_rows": [], "generated_rows": [], "id": "F6.4-000148-P3", "question": "Find alternative therapies targeting resistance genes for Capivasertib in Prostate Cancer.", "gold_cypher": "MATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t1:Therapy)\nWHERE (\n  toLower(t1.name) = toLower('Capivasertib')\n  OR any(s IN coalesce(t1.synonyms, []) WHERE toLower(s) = toLower('Capivasertib'))\n  OR toLower(t1.name) CONTAINS toLower('Capivasertib')\n)\n  AND toLower(rel.effect) = 'resistance'\n  AND (\n    toLower(rel.disease_name) CONTAINS 'prostate'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nWITH CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol\nWHERE gene_symbol IS NOT NULL\nMATCH (t2:Therapy)-[r:TARGETS]->(tg:Gene)\nWHERE (\n  toLower(tg.symbol) = toLower(gene_symbol)\n  OR any(s IN coalesce(tg.synonyms, []) WHERE toLower(s) = toLower(gene_symbol))\n)\n  AND toLower(t2.name) <> toLower('Capivasertib')\nRETURN\n  gene_symbol,\n  t2.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Tarloxotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tarloxotinib'))\n  OR toLower(t.name) CONTAINS toLower('Tarloxotinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100", "error": null, "latency_ms": 13579.975326000067, "input_tokens": 214, "output_tokens": 151, "tokens_per_second": 11.119313281143972, "gold_rows": [{"gene_symbol": "EGFR", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB2", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB3", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB4", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}], "generated_rows": [{"gene_symbol": "EGFR", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB2", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB3", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}, {"gene_symbol": "ERBB4", "therapy_name": "Tarloxotinib", "targets_moa": "Epidermal growth factor receptor inhibitor", "ref_sources": ["PubMed"], "ref_ids": ["33355298"], "ref_urls": ["https://pubmed.ncbi.nlm.nih.gov/33355298/"]}], "id": "F1.2-000189", "question": "Which genes does Tarloxotinib target?", "gold_cypher": "MATCH (t:Therapy)-[r:TARGETS]->(g:Gene)\nWHERE (\n  toLower(t.name) = toLower('Tarloxotinib')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Tarloxotinib'))\n  OR toLower(t.name) CONTAINS toLower('Tarloxotinib')\n)\nRETURN\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  r.moa AS targets_moa,\n  coalesce(r.ref_sources, []) AS ref_sources,\n  coalesce(r.ref_ids, []) AS ref_ids,\n  coalesce(r.ref_urls, []) AS ref_urls\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMD6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMD6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 25986.880208000002, "input_tokens": 230, "output_tokens": 299, "tokens_per_second": 11.505805914630473, "gold_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "generated_rows": [{"variant_name": "RAD50 L1237F", "gene_symbol": "RAD50", "therapy_name": "Irinotecan", "effect": "sensitivity", "disease_name": "Ureter Small Cell Carcinoma", "pmids": ["24934408"]}], "id": "F6.2-000127", "question": "What therapies target TOP1 but NOT PSMD6, and have biomarker evidence in Ureter Small Cell Carcinoma?", "gold_cypher": "MATCH (t:Therapy)-[:TARGETS]->(gi:Gene)\nWHERE toLower(gi.symbol) = toLower('TOP1')\n   OR any(s IN coalesce(gi.synonyms, []) WHERE toLower(s) = toLower('TOP1'))\nOPTIONAL MATCH (t)-[:TARGETS]->(gx:Gene)\nWHERE toLower(gx.symbol) = toLower('PSMD6')\n   OR any(s IN coalesce(gx.synonyms, []) WHERE toLower(s) = toLower('PSMD6'))\nWITH t, gi, gx\nWHERE gx IS NULL\nMATCH (b:Biomarker)-[rel:AFFECTS_RESPONSE_TO]->(t)\nWHERE (\n    toLower(rel.disease_name) CONTAINS 'ureter' AND\n    toLower(rel.disease_name) CONTAINS 'small' AND\n    toLower(rel.disease_name) CONTAINS 'cell' AND\n    toLower(rel.disease_name) CONTAINS 'carcinoma'\n  )\nOPTIONAL MATCH (b)-[:VARIANT_OF]->(g:Gene)\nRETURN\n  CASE WHEN b:Variant THEN b.name ELSE NULL END AS variant_name,\n  CASE WHEN b:Gene THEN b.symbol ELSE g.symbol END AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
{"syntactic_valid": true, "execution_success": true, "result_match": true, "generated_cypher": "MATCH (v:Variant {name: 'PTEN Loss'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100", "error": null, "latency_ms": 16239.214630000106, "input_tokens": 220, "output_tokens": 176, "tokens_per_second": 10.837962549916668, "gold_rows": [{"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["27091708"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["21358673"]}], "generated_rows": [{"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Her2-receptor Positive Breast Cancer", "pmids": ["27091708"]}, {"variant_name": "PTEN Loss", "gene_symbol": "PTEN", "therapy_name": "Everolimus", "effect": "sensitivity", "disease_name": "Breast Cancer", "pmids": ["21358673"]}], "id": "F2.2-000090-S2-P2", "question": "Does PTEN Loss predict response to Everolimus in Mammary Tumor?", "gold_cypher": "MATCH (v:Variant {name: 'PTEN Loss'})-[:VARIANT_OF]->(g:Gene)\nMATCH (v)-[rel:AFFECTS_RESPONSE_TO]->(t:Therapy)\nWHERE (\n  toLower(t.name) = toLower('Everolimus')\n  OR any(s IN coalesce(t.synonyms, []) WHERE toLower(s) = toLower('Everolimus'))\n  OR toLower(t.name) CONTAINS toLower('Everolimus')\n)\nAND (\n    toLower(rel.disease_name) CONTAINS 'breast'\n  )\nRETURN\n  v.name AS variant_name,\n  g.symbol AS gene_symbol,\n  t.name AS therapy_name,\n  rel.effect AS effect,\n  rel.disease_name AS disease_name,\n  coalesce(rel.pmids, []) AS pmids\nLIMIT 100\n"}
